Literature DB >> 5069726

An enteroglucagon tumour.

S R Bloom.   

Abstract

A hormone-secreting renal tumour that affected small bowel structure, motility, and function has been described by Gleeson et al (1971). The present studies show that the large amount of glucagon-like immunoreactivity which could be extracted from this tumour had the molecular weight, action on plasma insulin and glucose in vivo, and immunological reactions of the gut hormone enteroglucagon. This is the first enteroglucagonoma to be reported.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5069726      PMCID: PMC1412275          DOI: 10.1136/gut.13.7.520

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Glucagon antibodies and an immunoassay for glucagon.

Authors:  R H UNGER; A M EISENTRAUT; M S McCALL; L L MADISON
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

3.  Extractable glucagon of the human pancreas.

Authors:  A J KENNY
Journal:  J Clin Endocrinol Metab       Date:  1955-09       Impact factor: 5.958

4.  Stimulation of glucagon secretion by oral glucose.

Authors:  E Samols; J Tyler; G Marri; V Marks
Journal:  Lancet       Date:  1965-12-18       Impact factor: 79.321

5.  Pancreatic-glucagon-like immunoreactivity after intravenous insulin in normals and chronic-pancreatitis patients.

Authors:  I Persson; F Gyntelberg; L G Heding; J Boss-Nielsen
Journal:  Acta Endocrinol (Copenh)       Date:  1971-06

6.  Demonstration and characterization of a second fraction of glucagon-like immunoreactivity in jejunal extracts.

Authors:  I Valverde; D Rigopoulou; J Exton; A Ohneda; A Eisentraut; R H Unger
Journal:  Am J Med Sci       Date:  1968-06       Impact factor: 2.378

7.  The production of glucagon antibodies in rabbits.

Authors:  L G Heding
Journal:  Horm Metab Res       Date:  1969-03       Impact factor: 2.936

8.  Molecular size of extractable glucagon and glucagon-like immunoreactivity (GLI) in plasma.

Authors:  I Valverde; D Rigopoulou; J Marco; G R Faloona; R H Unger
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

9.  Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function.

Authors:  M H Gleeson; S R Bloom; J M Polak; K Henry; R H Dowling
Journal:  Gut       Date:  1971-10       Impact factor: 23.059

10.  Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.

Authors:  R H Unger; A Ohneda; I Valverde; A M Eisentraut; J Exton
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

View more
  57 in total

Review 1.  Gut adaptation and the glucagon-like peptides.

Authors:  D J Drucker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

2.  Cardiovascular and endocrine responses to feeding in the young calf.

Authors:  S R Bloom; A V Edwards; R N Hardy; K Malinowska; M Silver
Journal:  J Physiol       Date:  1975-12       Impact factor: 5.182

Review 3.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

4.  Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog.

Authors:  T E Adrian; J S Thompson; E M Quigley
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

5.  Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis.

Authors:  G R Lawson; R Nelson; M F Laker; M A Ghatei; S R Bloom; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

Review 6.  Enteral nutrition and the small intestine.

Authors:  A P Jenkins; R P Thompson
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

7.  Increased ileal proglucagon expression after jejunectomy is not suppressed by inhibition of bowel growth.

Authors:  M H Ulshen; E C Hoyt; C R Fuller; M A Ghatei; S R Bloom; P K Lund
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

Review 8.  Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

9.  Glucagonoma syndrome demonstrating giant duodenal villi.

Authors:  F M Stevens; R W Flanagan; D O'Gorman; K D Buchanan
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

10.  Role of gastrointestinal hormones in the response to massive resection of the small bowel.

Authors:  A A D'sa; K D Buchanan
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.